Literature DB >> 12388541

Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy.

Jessica L Walcott1, Diane E Merry.   

Abstract

Spinal and bulbar muscular atrophy (SBMA, Kennedy's disease) is one of a group of progressive neurodegenerative diseases resulting from a polyglutamine repeat expansion. In SBMA the polymorphic trinucleotide CAG repeat in exon 1 of the androgen receptor (AR) gene is increased, resulting in expansion of a polyglutamine tract. Patient autopsy material reveals neuronal intranuclear inclusions (NII) in affected regions that contain only amino-terminal epitopes of the AR. Cell models have previously been unable to produce intranuclear inclusions containing only a portion of the AR. We report here the creation of an inducible cell model of SBMA that reproduces this important characteristic of disease pathology. PC12 cells expressing highly expanded AR form ubiquitinated intranuclear inclusions containing amino-terminal epitopes of the AR as well as heat shock proteins. Inclusions appear as distinct granular electron-dense structures in the nucleus by immunoelectron microscopy. Dihydrotestosterone treatment of mutant AR-expressing cells results in increased inclusion load. This model mimics the formation of ubiquitinated intranuclear inclusions containing the amino-terminal portion of AR observed in patient tissue and reveals a role for ligand in the pathogenesis of SBMA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388541     DOI: 10.1074/jbc.M209466200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  SIRT1 modulates aggregation and toxicity through deacetylation of the androgen receptor in cell models of SBMA.

Authors:  Heather L Montie; Richard G Pestell; Diane E Merry
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

2.  Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

3.  Absence of disturbed axonal transport in spinal and bulbar muscular atrophy.

Authors:  Bilal Malik; Niranjanan Nirmalananthan; Lynsey G Bilsland; Albert R La Spada; Michael G Hanna; Giampietro Schiavo; Jean-Marc Gallo; Linda Greensmith
Journal:  Hum Mol Genet       Date:  2011-02-11       Impact factor: 6.150

Review 4.  Spinal and bulbar muscular atrophy: pathogenesis and clinical management.

Authors:  C Grunseich; C Rinaldi; K H Fischbeck
Journal:  Oral Dis       Date:  2013-05-09       Impact factor: 3.511

5.  A polyglutamine expansion disease protein sequesters PTIP to attenuate DNA repair and increase genomic instability.

Authors:  Hong Xiao; Zhigang Yu; Yipin Wu; John Nan; Diane E Merry; JoAnn M Sekiguchi; David O Ferguson; Andrew P Lieberman; Gregory R Dressler
Journal:  Hum Mol Genet       Date:  2012-06-26       Impact factor: 6.150

Review 6.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

Review 7.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

8.  Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy.

Authors:  Kaiguo Mo; Zak Razak; Pengcheng Rao; Zhigang Yu; Hiroaki Adachi; Masahisa Katsuno; Gen Sobue; Andrew P Lieberman; J Timothy Westwood; D Ashley Monks
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

9.  Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.

Authors:  Heather L Montie; Maria S Cho; Latia Holder; Yuhong Liu; Andrey S Tsvetkov; Steven Finkbeiner; Diane E Merry
Journal:  Hum Mol Genet       Date:  2009-03-11       Impact factor: 6.150

10.  Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.

Authors:  M J Schiewer; L M Morey; C J Burd; Y Liu; D E Merry; S-M Ho; K E Knudsen
Journal:  Oncogene       Date:  2008-12-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.